HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stefan Joos Selected Research
Stefan Joos Research Topics
Disease
19
Neoplasms (Cancer)
09/2015 - 07/2003
7
Squamous Cell Carcinoma of Head and Neck
08/2010 - 09/2003
4
Glioma (Gliomas)
02/2010 - 10/2005
4
Medulloblastoma
04/2009 - 05/2004
3
Liposarcoma
09/2006 - 05/2002
2
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2009 - 12/2005
2
Carcinogenesis
02/2006 - 03/2004
2
Hodgkin Disease (Hodgkin's Disease)
12/2005 - 05/2003
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2015
1
Hepatocellular Carcinoma (Hepatoma)
10/2009
1
Brain Neoplasms (Brain Tumor)
12/2008
1
Glioblastoma (Glioblastoma Multiforme)
12/2008
1
Lymphatic Metastasis
05/2008
1
Astrocytoma (Pilocytic Astrocytoma)
05/2008
1
Microsatellite Instability
05/2007
1
Disease Progression
02/2007
1
Mouth Neoplasms (Oral Cancer)
02/2007
1
Thymoma (Thymic Carcinoma)
11/2006
1
Neurofibrosarcoma (MPNST)
09/2006
1
Sarcoma (Soft Tissue Sarcoma)
09/2006
1
Malignant Fibrous Histiocytoma
09/2006
1
Basal Cell Carcinoma (Rodent Ulcer)
05/2006
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2005
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2003
1
Breast Neoplasms (Breast Cancer)
07/2003
1
Sclerosis
02/2002
1
Lymphoma (Lymphomas)
02/2002
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
09/2015 - 07/2003
4
DNA (Deoxyribonucleic Acid)
IBA
04/2009 - 12/2005
3
Biological Products
IBA
05/2008 - 05/2002
2
Oncogene Proteins (Oncogene Protein)
IBA
10/2009 - 09/2003
2
Phosphotransferases (Kinase)
IBA
12/2008 - 05/2008
2
Messenger RNA (mRNA)
IBA
05/2008 - 02/2006
2
A-Form DNA (A-DNA)
IBA
01/2007 - 09/2006
2
Cyclin D1
IBA
02/2006 - 05/2004
1
Apoptosomes (Apoptosome)
IBA
09/2015
1
Mitogen-Activated Protein Kinase Phosphatases
IBA
02/2010
1
Mitogen-Activated Protein Kinases
IBA
02/2010
1
SOXB1 Transcription Factors
IBA
01/2010
1
Elements
IBA
10/2009
1
Carrier Proteins (Binding Protein)
IBA
10/2009
1
Pyridinolcarbamate (P23)
IBA
04/2009
1
Biomarkers (Surrogate Marker)
IBA
04/2009
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
12/2008
1
Troglitazone (Rezulin)
FDA Link
12/2008
1
Pharmaceutical Preparations
IBA
12/2008
1
Ligands
IBA
12/2008
1
PPAR gamma
IBA
12/2008
1
Mitogens
IBA
05/2008
1
Oligonucleotides
IBA
05/2008
1
Small Interfering RNA (siRNA)
IBA
05/2008
1
Transforming Growth Factor beta (TGF-beta)
IBA
05/2008
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
05/2007
1
Survivin
IBA
02/2007
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
01/2007
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
11/2006
1
NF-kappa B (NF-kB)
IBA
12/2005
1
Transcription Factors (Transcription Factor)
IBA
12/2005
1
Cyclin-Dependent Kinase Inhibitor p16
IBA
04/2005
1
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
04/2005
1
Stathmin
IBA
05/2004
1
Codon (Codons)
IBA
10/2003
1
Apoptosis Regulatory Proteins
IBA
07/2003
1
HMGB1 Protein (HMG1)
IBA
07/2003
1
Proto-Oncogene Proteins c-rel
IBA
05/2003
1
Complementary DNA (cDNA)
IBA
06/2002
1
RNA (Ribonucleic Acid)
IBA
06/2002
1
LR 16
IBA
02/2002
Therapy/Procedure
8
Therapeutics
09/2015 - 07/2003
1
Heterologous Transplantation (Xenotransplantation)
10/2009
1
Radiotherapy
02/2007
1
Drug Therapy (Chemotherapy)
05/2004